Intense pulsed light combined with meibomian gland expression for chalazion management

Arch Soc Esp Oftalmol (Engl Ed). 2022 Sep;97(9):490-496. doi: 10.1016/j.oftale.2022.06.008. Epub 2022 Jul 2.

Abstract

Objective: To investigate the efficacy and safety of an intense pulsed light (IPL) combined IPL treatment protocol for meibomian gland dysfunction (MGD)/dry eye disease (DED) with IPL applied directly to the eyelids, associated with meibomian gland (MG) expression for the treatment of chalazion.

Material and methods: Retrospective case series study. Patients presenting with chalazion received a combined IPL therapy treatment consisting of using the usual IPL protocol for DGM/EOS using a fluence according to skin type according to Fitzpatrick, followed by a second phase (in the same session) of IPL application directly on the eyelids of both eyes using a fluence of 10J/cm2. All patients then received GM expression, eyelid hygiene, topical antibiotic and topical ocular anti-inflammatory medication. Adverse effects related to this protocol were assessed at each IPL session.

Results: Twenty-six chalazions from nineteen patients (24 eyes) with a mean age of 49.89±20.43 years were included. An average of 2.07±0.97 IPL sessions were required for chalazion resolution. The combined treatment of IPL protocol and GM expression showed 96.15% efficacy and no adverse effects were observed.

Conclusions: Combined IPL treatment for MGD/DED with IPL applied directly onto the eyelids and MGX could be effective and safe for the management of chalazions.

Keywords: Chalazion; Clalación; Disfunción de la glándula de Meibomio; Expresión de la glándula de Meibomio; Intense pulsed light; Luz pulsada intense; Meibomian gland dysfunction; Meibomian gland expression.

MeSH terms

  • Adult
  • Aged
  • Chalazion* / therapy
  • Dry Eye Syndromes* / therapy
  • Humans
  • Meibomian Gland Dysfunction* / therapy
  • Meibomian Glands
  • Middle Aged
  • Retrospective Studies